The ashwaghanda is a plant extract you can find in the ingredient lists of food supplements, but do you know what is it exactly? This article makes a statement of what the science says established concerning this extract: its definition and health effects on human.
Following an exploration of potential regulatory pathways for cannabidiol (CBD) products by an internal Food and Drug Administration (FDA) working group, the FDA concluded on January 26, 2023, that a new regulatory pathway for CBD is needed to provide the regulatory oversight necessary to manage risk. The Agency is prepared to work with Congress on this issue.
The EFSA’s Scientific Committee has assessed the exposure to copper from all dietary and non-dietary sources for the first time for this substance. He has concluded that the combined exposure to copper from all sources does not pose health concerns for the EU population.
The EFSA published on May 2022 an article related to the project “Microbiota analysis for risk assessment: evaluation of hazardous dietary substances and its potential role on the gut microbiome variability and dysbiosis in a special issue dedicated to the European Food Risk assessment (EU-FOR A) program.
EFSA’s assessment of the safety of dietary sugars has been postponed to 2021 due to the impact of the COVID-19 pandemic and
EFSA has assessed the risks to human health from the presence of aflatoxins in food. To carry out the risk assessment, the
Français